# SHINE Technologies

Source: https://onco.cc/companies/shine-technologies/  
OnCo record `shine-technologies` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

SHINE Technologies is a fusion-based isotope company that produces non-carrier-added Lu-177 (Ilumira) and is building the Chrysalis Mo-99 plant.

## Summary

SHINE Technologies, based in Janesville, Wisconsin, is a fusion-based isotope company that produces non-carrier-added lutetium-177, sold as Ilumira, and is building the Chrysalis molybdenum-99 plant. It has supplied lutetium-177 to radiopharmaceutical developers since 2022, its large-scale Mo-99 facility is under construction, and it holds long-term fusion energy ambitions. OnCo links it to the therapeutic isotope supply chain for Mo-99, Lu-177 and Ac-225. Whether a second Western source of lutetium-177 makes supply resilient enough for radioligand therapy to scale is the open question. The isotope supply chain page carries the wider picture.

## Fields

- Kind: Company
- Last checked: 2026-09-08
- Tags: supporting
- HQ: Janesville, WI
- Type: radiopharma
- Website: https://www.shinefusion.com

## Sources

- Official website: https://www.shinefusion.com

## Connected records

- fronts: [Radiopharmaceuticals & Theranostics](https://onco.cc/fronts/radiopharma/)
- technologies: [Research reactors for medical isotopes (Mo-99, Lu-177, I-131)](https://onco.cc/technologies/research-reactor-isotope-production/), [Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225)](https://onco.cc/technologies/therapy-isotope-supply-chain/)

---
JSON: https://onco.cc/api/v1/entities/shine-technologies.json